MedTrace Logo

Non-contrast Enhanced Cardiac Magnetic Resonance Normal Values and Imaging Protocols

NCT01728597 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-02-12

No results posted yet for this study

Summary

One of the main problems in cardiac magnetic resonance (MR) investigations is the strong dependence of the achieved image quality on optimal settings of sequence parameters and anatomical and physiological situations and it is well known that the diagnostic impact of cardiac MR investigations crucially depends on the adaption of imaging protocols to patients' state and ability to cooperate.

The aim of the present study is the evaluation and optimization of various 1.5 Tesla and 3 Tesla cardiac MR investigation protocols without application of contrast agent as well as the acquisition of normal values for new cardiac MR images techniques:

* normal myocardial morphology: T1-, T2- and T2\*-weighted imaging and acquisition of normal values of magnetic relaxation times (sequence- and protocol dependent),
* normal cardiac function: systolic and diastolic function (sequence- and protocol dependent),
* cardiac anatomy and coronary artery imaging: feasibility to evaluate length, diameter and blood flow (sequence- and protocol dependent),
* normal blood flow topologies in the heart and the surrounding great vessels: 2D- and 3D blood flow imaging and evaluation techniques (sequence- and protocol dependent).

Conditions

  • Healthy

Sponsors & Collaborators

  • Amt der Steiermärkischen Landesregierung, Abteilung 3

    collaborator UNKNOWN

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Ursula Reiter, PhD · Medical Unitersity Graz, Department of Radiology, Division of General Radiology

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2025-12-31
Completion
2027-12-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01728597 on ClinicalTrials.gov